We need to shine the light on perfusion device data to make the switch from a donor-centric to an organ-centric national system. If we work together now, we can reduce the wait list to zero in the future. If we don’t, we’ll have a system that hinders accessibility to game-changing innovations for the majority of patients.
The TAD Talk was presented by Dalton Shaull, Founder & Chief Executive Officer, OmniLife